Back to results
US 12,110,520 B2Granted
PH20 polypeptide variants, formulations and uses thereof
AssigneeHalozyme, Inc.
InventorsGe Wei, H. Michael Shepard, Qiping Zhao, Robert James Connor
Life of this patent
Estimating the term…
Abstract
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.
Claims35
A modified PH20 polypeptide, comprising one or more amino acid modifications in an unmodified PH20 polypeptide, wherein:
- the unmodified PH20 polypeptide consists of the amino acid sequence selected from the group consisting of SEQ ID NO:
- 3, 7 and 32-66;
- amino acid modifications are selected from the group consisting of amino acid replacements(s), deletion(s), and/or insertion(s);
- the modified PH20 polypeptide comprises an amino acid replacement at a position corresponding to residue 324, with reference to amino acid positions set forth in SEQ ID NO:
- 3;
- the replacement at the position corresponding to residue 324 is selected from the group consisting of A, D, H, M, N, R and S;
- corresponding amino acid positions are identified by alignment of the PH20 polypeptide with the polypeptide having the amino acid sequence of SEQ ID NO:
- 3;
- and
- the modified PH20 polypeptide has at least 91% sequence identity to a polypeptide having the amino acid sequence selected from the group consisting of SEQ ID NO:
- 3, 7 and 32-66.
8 more elements
Dependencies are inferred from the claim text.